| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8454742 | Lung Cancer | 2016 | 4 Pages |
Abstract
EGFR mutation must be investigated in HIV-NSCLC cases due to its predictive and prognostic impact, whereas KRAS mutation is of poor prognostic value. Clinicians should search for drugs dedicated to this target population.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Perrine Créquit, Anne-Marie Ruppert, Nathalie Rozensztajn, Valérie Gounant, T. Vieira, Virginie Poulot, Martine Antoine, Christos Chouaid, Marie Wislez, Jacques Cadranel, Armelle Lavole,